Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Harald Hampel(Eisai (United States)), Suzanne E. Schindler(Meharry Medical College)
Cited by 235
Related Papers
The Amyloid-β Pathway in Alzheimer’s Disease
|Molecular Psychiatry|2021|1.8k
The β-Secretase BACE1 in Alzheimer’s Disease
|Biological Psychiatry|2020|657
Designing the next-generation clinical care pathway for Alzheimer’s disease
|Nature Aging|2022|193
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
|Neurology Genetics|2021|53